|
1
|
Laher F, Richardson SI, Smith P, Sullivan PS, Abrahams AG, Asowata OE, Bitangumutwenzi P, Dabee S, Dollah A, Fernandez N, Langat RK, Bose DL, Likhitwonnawut U, Mullick R, Resop RS, Sutar J, Thompson-Hall A“N, Traeger MW, Tuyishime M, Wambui J, Bekker LG, Kaleebu P, McCormack S, O'Connor DH, Warren M, Torri T, Thyagarajan B. HIV Prevention in a Time of COVID-19: A Report from the HIVR4P // Virtual Conference 2021. AIDS Res Hum Retroviruses 2022; 38:350-358. [PMID: 34714100 PMCID: PMC9131040 DOI: 10.1089/aid.2021.0138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Abstract
The HIV Research for Prevention (HIVR4P) conference catalyzes knowledge sharing on biomedical HIV prevention interventions such as HIV vaccines, antibody infusions, pre-exposure prophylaxis, and microbicides in totality-from the molecular details and delivery formulations to the behavioral, social, and structural underpinnings. HIVR4P // Virtual was held over the course of 2 weeks on January 27-28 and February 3-4, 2021 as the coronavirus disease 2019 (COVID-19) pandemic continued to inflict unprecedented harm globally. The HIVR4P community came together with 1,802 researchers, care providers, policymakers, implementers, and advocates from 92 countries whose expertise spanned the breadth of the HIV prevention pipeline from preclinical to implementation. The program included 113 oral and 266 poster presentations. This article presents a brief summary of the conference highlights. Complete abstracts, webcasts, and daily rapporteur summaries may be found on the conference website (https://www.hivr4p.org/).
Collapse
Affiliation(s)
- Fatima Laher
- University of the Witwatersrand, Johannesburg, South Africa
| | - Simone I. Richardson
- University of the Witwatersrand, Johannesburg, South Africa
- National Institute for Communicable Diseases, Johannesburg, South Africa
| | - Philip Smith
- The Desmond Tutu HIV Research Centre, Cape Town, South Africa
| | | | | | | | | | - Smritee Dabee
- Seattle Children's Research Institute, Seattle, Washington, USA
| | | | | | | | - Devi Leena Bose
- International AIDS Vaccine Initiative (IAVI), New Delhi, India
| | | | - Ranajoy Mullick
- International AIDS Vaccine Initiative (IAVI), New Delhi, India
| | - Rachel S. Resop
- The George Washington University, Washington, District of Columbia, USA
| | - Jyoti Sutar
- Indian Council of Medical Research (ICMR), Mumbai, India
| | | | | | | | - Jacque Wambui
- AFROCAB Treatment Access Partnerships, Nairobi, Kenya
| | | | - Pontiano Kaleebu
- Uganda Virus Research Institute & MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda
| | | | | | | | | | | |
Collapse
|
|
2
|
Masson L, Abrahams AG, Manhanzva MT. Reconceptualizing bacterial vaginosis treatment. Nat Microbiol 2022; 7:365-366. [PMID: 35241797 DOI: 10.1038/s41564-022-01063-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Lindi Masson
- Disease Elimination Program, Life Sciences Discipline, Burnet Institute, Melbourne, Victoria, Australia. .,Institute of Infectious Disease and Molecular Medicine, Department of Pathology, University of Cape Town, Cape Town, South Africa. .,Centre for the AIDS Programme of Research in South Africa, Durban, South Africa. .,Central Clinical School, Monash University, Melbourne, Victoria, Australia.
| | - Andrea G Abrahams
- Institute of Infectious Disease and Molecular Medicine, Department of Pathology, University of Cape Town, Cape Town, South Africa
| | - Monalisa T Manhanzva
- Institute of Infectious Disease and Molecular Medicine, Department of Pathology, University of Cape Town, Cape Town, South Africa
| |
Collapse
|